Get started
geraldelli

Long RVNC

Long
Revance Therapeutics, Inc. (NASDAQ:RVNC)  
geraldelli  
NASDAQ:RVNC   Revance Therapeutics, Inc.
botulinum healthcare biotech
2
0
botulinum healthcare biotech
Long RVNC if it breaks 40.06 (the historic high). Ipo-U Turn pattern. Company is developing less invasive methods for botulinum toxin application (biggest competitor is known as Botox).
Currently Trading at 997M Mkt Cap.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.